Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKinsey
Colorcon
Fuji
Argus Health
Julphar
Farmers Insurance
US Army
US Department of Justice

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,854,259

« Back to Dashboard

Summary for Patent: 5,854,259
Title: Quinoline type mevalonolactones
Abstract:Described herein are mevalonolactone derivatives having a quinoline ring of formula (I) ##STR1## wherein the R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, Y and Z variables are described therein.
Inventor(s): Fujikawa; Yoshihiro (Funabashi, JP), Suzuki; Mikio (Funabashi, JP), Iwasaki; Hiroshi (Funabashi, JP), Sakashita; Mitsuaki (Saitama-ken, JP), Kitahara; Masaki (Saitama-ken, JP)
Assignee: Nissan Chemical Industries Ltd. (Tokyo, JP)
Application Number:07/978,884
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 5,854,259

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,854,259

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-207224Aug 20, 1987
Japan63-15585Jan 26, 1988
Japan63-193606Aug 03, 1988

International Patents Family Members for US Patent 5,854,259

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 3852243 ➤ Try a Free Trial
European Patent Office 0304063 ➤ Try a Free Trial
Spain 2067460 ➤ Try a Free Trial
Greece 3015186 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Baxter
Queensland Health
Medtronic
Federal Trade Commission
Express Scripts
McKinsey
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.